{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T20:47:03Z","timestamp":1793652423296,"version":"4.5.1"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T00:00:00Z","timestamp":1773619200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T00:00:00Z","timestamp":1773619200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"\u4e2d\u56fd\u56fd\u5bb6\u91cd\u70b9\u7814\u53d1\u9879\u76ee; \u4e2d\u592e\u9ad8\u6821\u57fa\u7840\u7814\u7a76\u7ecf\u8d39"},{"DOI":"10.13039\/501100012166","name":"National Key R&D Program of China","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sig Transduct Target Ther"],"DOI":"10.1038\/s41392-026-02640-5","type":"journal-article","created":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T10:47:21Z","timestamp":1773658041000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["A biosafe mouse model for SARS-CoV-2 infection that more realistically simulates COVID-19 symptoms"],"prefix":"10.1038","volume":"11","author":[{"given":"Xiaoya","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingjian","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jikai","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shimin","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jintao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhengzhong","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peiliang","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1300-4652","authenticated-orcid":false,"given":"Yu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,16]]},"reference":[{"key":"2640_CR1","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1038\/s41586-020-2008-3","volume":"579","author":"F Wu","year":"2020","unstructured":"Wu, F. et al. A new coronavirus associated with human respiratory disease in China. Nature 579, 265\u2013269 (2020).","journal-title":"Nature"},{"key":"2640_CR2","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1056\/NEJMoa2001017","volume":"382","author":"N Zhu","year":"2020","unstructured":"Zhu, N. et al. A novel coronavirus from patients with pneumonia in China, 2019. N. Engl. J. Med. 382, 727\u2013733 (2020).","journal-title":"N. Engl. J. Med."},{"key":"2640_CR3","doi-asserted-by":"publisher","first-page":"100029","DOI":"10.1016\/j.cellin.2022.100029","volume":"1","author":"Y Chen","year":"2022","unstructured":"Chen, Y. et al. Emerging SARS-CoV-2 variants: why, how, and what\u2019s next? Cell Insight 1, 100029 (2022).","journal-title":"Cell Insight"},{"key":"2640_CR4","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1002\/jmv.25681","volume":"92","author":"Y Chen","year":"2020","unstructured":"Chen, Y., Liu, Q. & Guo, D. Emerging coronaviruses: genome structure, replication, and pathogenesis. J. Med. Virol. 92, 418\u2013423 (2020).","journal-title":"J. Med. Virol."},{"key":"2640_CR5","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1080\/22221751.2020.1725399","volume":"9","author":"L Chen","year":"2020","unstructured":"Chen, L. et al. RNA based mNGS approach identifies a novel human coronavirus from two individual pneumonia cases in 2019 Wuhan outbreak. Emerg. Microbes Infect. 9, 313\u2013319 (2020).","journal-title":"Emerg. Microbes Infect."},{"key":"2640_CR6","doi-asserted-by":"publisher","first-page":"3306","DOI":"10.1007\/s00330-020-06731-x","volume":"30","author":"Y Pan","year":"2020","unstructured":"Pan, Y. et al. Initial CT findings and temporal changes in patients with the novel coronavirus pneumonia (2019-nCoV): a study of 63 patients in Wuhan, China. Eur. Radiol. 30, 3306\u20133309 (2020).","journal-title":"Eur. Radiol."},{"key":"2640_CR7","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1016\/S0140-6736(20)30628-0","volume":"395","author":"P Mehta","year":"2020","unstructured":"Mehta, P. et al. COVID-19: consider cytokine storm syndromes and immunosuppression. Lancet Lond. Engl. 395, 1033\u20131034 (2020).","journal-title":"Lancet Lond. Engl."},{"key":"2640_CR8","doi-asserted-by":"publisher","first-page":"1953","DOI":"10.1056\/NEJMoa030781","volume":"348","author":"TG Ksiazek","year":"2003","unstructured":"Ksiazek, T. G. et al. A novel coronavirus associated with severe acute respiratory syndrome. N. Engl. J. Med. 348, 1953\u20131966 (2003).","journal-title":"N. Engl. J. Med."},{"key":"2640_CR9","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1038\/s41564-020-0688-y","volume":"5","author":"M Letko","year":"2020","unstructured":"Letko, M., Marzi, A. & Munster, V. Functional assessment of cell entry and receptor usage for SARS-CoV-2 and other lineage B betacoronaviruses. Nat. Microbiol. 5, 562\u2013569 (2020).","journal-title":"Nat. Microbiol."},{"key":"2640_CR10","doi-asserted-by":"publisher","first-page":"2433","DOI":"10.1080\/22221751.2020.1838955","volume":"9","author":"R Rathnasinghe","year":"2020","unstructured":"Rathnasinghe, R. et al. Comparison of transgenic and adenovirus hACE2 mouse models for SARS-CoV-2 infection. Emerg. Microbes Infect. 9, 2433\u20132445 (2020).","journal-title":"Emerg. Microbes Infect."},{"key":"2640_CR11","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-19891-7","volume":"11","author":"FS Oladunni","year":"2020","unstructured":"Oladunni, F. S. et al. Lethality of SARS-CoV-2 infection in K18 human angiotensin-converting enzyme 2 transgenic mice. Nat. Commun. 11, 6122 (2020).","journal-title":"Nat. Commun."},{"key":"2640_CR12","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1038\/s41586-020-2312-y","volume":"583","author":"L Bao","year":"2020","unstructured":"Bao, L. et al. The pathogenicity of SARS-CoV-2 in hACE2 transgenic mice. Nature 583, 830\u2013833 (2020).","journal-title":"Nature"},{"key":"2640_CR13","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.cell.2020.05.027","volume":"182","author":"R-D Jiang","year":"2020","unstructured":"Jiang, R.-D. et al. Pathogenesis of SARS-CoV-2 in transgenic mice expressing human angiotensin-converting enzyme 2. Cell 182, 50\u201358.e8 (2020).","journal-title":"Cell"},{"key":"2640_CR14","doi-asserted-by":"publisher","DOI":"10.1128\/mbio.00720-25","volume":"16","author":"A Pons-Gr\u00edfols","year":"2025","unstructured":"Pons-Gr\u00edfols, A. et al. A human-ACE2 knock-in mouse model for SARS-CoV-2 infection recapitulates respiratory disorders but avoids neurological disease associated with the transgenic K18-hACE2 model. mBio. 16, e0072025 (2025).","journal-title":"mBio."},{"key":"2640_CR15","doi-asserted-by":"publisher","DOI":"10.1080\/22221751.2024.2353302","volume":"13","author":"Z Zhang","year":"2024","unstructured":"Zhang, Z. et al. The lethal K18-hACE2 knock-in mouse model mimicking the severe pneumonia of COVID-19 is practicable for antiviral development. Emerg. Microbes Infect. 13, 2353302 (2024).","journal-title":"Emerg. Microbes Infect."},{"key":"2640_CR16","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2025.105619","volume":"113","author":"F Ana-Sosa-Batiz","year":"2025","unstructured":"Ana-Sosa-Batiz, F. et al. A humanised ACE2, TMPRSS2, and FCGRT mouse model reveals the protective efficacy of anti-receptor binding domain antibodies elicited by SARS-CoV-2 hybrid immunity. EBioMedicine 113, 105619 (2025).","journal-title":"EBioMedicine"},{"key":"2640_CR17","doi-asserted-by":"publisher","first-page":"1428711","DOI":"10.3389\/fimmu.2024.1428711","volume":"15","author":"H Liu","year":"2024","unstructured":"Liu, H. et al. Establishment and characterization of an hACE2\/hTMPRSS2 knock-in mouse model to study SARS-CoV-2. Front. Immunol. 15, 1428711 (2024).","journal-title":"Front. Immunol."},{"key":"2640_CR18","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20201241","volume":"217","author":"B Israelow","year":"2020","unstructured":"Israelow, B. et al. Mouse model of SARS-CoV-2 reveals inflammatory role of type I interferon signaling. J. Exp. Med. 217, e20201241 (2020).","journal-title":"J. Exp. Med."},{"key":"2640_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2021.102699","volume":"24","author":"EN Gary","year":"2021","unstructured":"Gary, E. N. et al. A novel mouse AAV6 hACE2 transduction model of wild-type SARS-CoV-2 infection studied using synDNA immunogens. iScience 24, 102699 (2021).","journal-title":"iScience"},{"key":"2640_CR20","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1009758","volume":"17","author":"C-P Sun","year":"2021","unstructured":"Sun, C.-P. et al. Rapid generation of mouse model for emerging infectious disease with the case of severe COVID-19. PLoS Pathog. 17, e1009758 (2021).","journal-title":"PLoS Pathog."},{"key":"2640_CR21","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1038\/s41586-020-2708-8","volume":"586","author":"KH Dinnon","year":"2020","unstructured":"Dinnon, K. H. et al. A mouse-adapted model of SARS-CoV-2 to test COVID-19 countermeasures. Nature 586, 560\u2013566 (2020).","journal-title":"Nature"},{"key":"2640_CR22","doi-asserted-by":"publisher","first-page":"1603","DOI":"10.1126\/science.abc4730","volume":"369","author":"H Gu","year":"2020","unstructured":"Gu, H. et al. Adaptation of SARS-CoV-2 in BALB\/c mice for testing vaccine efficacy. Science 369, 1603\u20131607 (2020).","journal-title":"Science"},{"key":"2640_CR23","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1038\/s41392-022-01087-8","volume":"7","author":"C Fan","year":"2022","unstructured":"Fan, C. et al. Animal models for COVID-19: advances, gaps and perspectives. Signal Transduct. Target. Ther. 7, 220 (2022).","journal-title":"Signal Transduct. Target. Ther."},{"key":"2640_CR24","doi-asserted-by":"publisher","first-page":"3032","DOI":"10.1002\/jmv.27718","volume":"94","author":"S Qin","year":"2022","unstructured":"Qin, S. et al. Review of selected animal models for respiratory coronavirus infection and its application in drug research. J. Med. Virol. 94, 3032\u20133042 (2022).","journal-title":"J. Med. Virol."},{"key":"2640_CR25","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-89013-w","volume":"11","author":"CJ C\u00e1ceres","year":"2021","unstructured":"C\u00e1ceres, C. J. et al. Efficacy of GC-376 against SARS-CoV-2 virus infection in the K18 hACE2 transgenic mouse model. Sci. Rep. 11, 9609 (2021).","journal-title":"Sci. Rep."},{"key":"2640_CR26","doi-asserted-by":"publisher","first-page":"535","DOI":"10.3390\/v14030535","volume":"14","author":"M Carossino","year":"2022","unstructured":"Carossino, M. et al. Fatal neurodissemination and SARS-CoV-2 tropism in K18-hACE2 mice is only partially dependent on hACE2 expression. Viruses 14, 535 (2022).","journal-title":"Viruses"},{"key":"2640_CR27","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1128\/JVI.02012-06","volume":"81","author":"PB McCray","year":"2007","unstructured":"McCray, P. B. et al. Lethal infection of K18-hACE2 mice infected with severe acute respiratory syndrome coronavirus. J. Virol. 81, 813\u2013821 (2007).","journal-title":"J. Virol."},{"key":"2640_CR28","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1038\/s41421-021-00293-y","volume":"7","author":"J Liu","year":"2021","unstructured":"Liu, J. et al. hACE2 Fc-neutralization antibody cocktail provides synergistic protection against SARS-CoV-2 and its spike RBD variants. Cell Discov. 7, 54 (2021).","journal-title":"Cell Discov."},{"key":"2640_CR29","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20202135","volume":"218","author":"E Song","year":"2021","unstructured":"Song, E. et al. Neuroinvasion of SARS-CoV-2 in human and mouse brain. J. Exp. Med. 218, e20202135 (2021).","journal-title":"J. Exp. Med."},{"key":"2640_CR30","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1177\/03009858211066841","volume":"59","author":"E Vidal","year":"2022","unstructured":"Vidal, E. et al. Chronological brain lesions after SARS-CoV-2 infection in hACE2-transgenic mice. Vet. Pathol. 59, 613\u2013626 (2022).","journal-title":"Vet. Pathol."},{"key":"2640_CR31","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2207210120","volume":"120","author":"K Liu","year":"2023","unstructured":"Liu, K. et al. An inducible hACE2 transgenic mouse model recapitulates SARS-CoV-2 infection and pathogenesis in vivo. Proc. Natl. Acad. Sci. USA 120, e2207210120 (2023).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"2640_CR32","doi-asserted-by":"publisher","first-page":"11518","DOI":"10.1128\/JVI.76.22.11518-11529.2002","volume":"76","author":"J Ortego","year":"2002","unstructured":"Ortego, J., Escors, D., Laude, H. & Enjuanes, L. Generation of a replication-competent, propagation-deficient virus vector based on the transmissible gastroenteritis coronavirus genome. J. Virol. 76, 11518\u201311529 (2002).","journal-title":"J. Virol."},{"key":"2640_CR33","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1009439","volume":"17","author":"X Ju","year":"2021","unstructured":"Ju, X. et al. A novel cell culture system modeling the SARS-CoV-2 life cycle. PLOS Pathog. 17, e1009439 (2021).","journal-title":"PLOS Pathog."},{"key":"2640_CR34","doi-asserted-by":"publisher","first-page":"2229","DOI":"10.1016\/j.cell.2021.02.044","volume":"184","author":"X Zhang","year":"2021","unstructured":"Zhang, X. et al. A trans-complementation system for SARS-CoV-2 recapitulates authentic viral replication without virulence. Cell 184, 2229\u20132238.e13 (2021).","journal-title":"Cell"},{"key":"2640_CR35","doi-asserted-by":"publisher","DOI":"10.1128\/mSphere.00235-21","volume":"6","author":"T Gan","year":"2021","unstructured":"Gan, T. et al. Development of a new reverse genetics system for Ebola Virus. mSphere 6, e00235-21 (2021).","journal-title":"mSphere"},{"key":"2640_CR36","doi-asserted-by":"publisher","first-page":"3017","DOI":"10.1002\/jmv.27738","volume":"94","author":"W Wang","year":"2022","unstructured":"Wang, W., Peng, X., Jin, Y., Pan, J.-A. & Guo, D. Reverse genetics systems for SARS-CoV-2. J. Med. Virol. 94, 3017\u20133031 (2022).","journal-title":"J. Med. Virol."},{"key":"2640_CR37","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1016\/j.virs.2024.03.009","volume":"39","author":"Y Li","year":"2024","unstructured":"Li, Y. et al. An optimized high-throughput SARS-CoV-2 dual reporter trans-complementation system for antiviral screening in vitro and in vivo. Virol. Sin. 39, 447\u2013458 (2024).","journal-title":"Virol. Sin."},{"key":"2640_CR38","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1038\/s41421-023-00536-0","volume":"9","author":"B Yang","year":"2023","unstructured":"Yang, B. et al. A tissue specific-infection mouse model of SARS-CoV-2. Cell Discov. 9, 43 (2023).","journal-title":"Cell Discov."},{"key":"2640_CR39","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","volume":"395","author":"C Huang","year":"2020","unstructured":"Huang, C. et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 395, 497\u2013506 (2020).","journal-title":"Lancet"},{"key":"2640_CR40","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1016\/S2213-2600(20)30076-X","volume":"8","author":"Z Xu","year":"2020","unstructured":"Xu, Z. et al. Pathological findings of COVID-19 associated with acute respiratory distress syndrome. Lancet Respir. Med. 8, 420\u2013422 (2020).","journal-title":"Lancet Respir. Med."},{"key":"2640_CR41","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1007\/978-1-59745-471-1_18","volume":"530","author":"S Feil","year":"2009","unstructured":"Feil, S., Valtcheva, N. & Feil, R. Inducible Cre mice. Methods Mol. Biol. Clifton NJ 530, 343\u2013363 (2009).","journal-title":"Methods Mol. Biol. Clifton NJ"},{"key":"2640_CR42","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pbio.3001333","volume":"19","author":"SM Kissler","year":"2021","unstructured":"Kissler, S. M. et al. Viral dynamics of acute SARS-CoV-2 infection and applications to diagnostic and public health strategies. PLoS Biol. 19, e3001333 (2021).","journal-title":"PLoS Biol."},{"key":"2640_CR43","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1016\/j.it.2021.02.003","volume":"42","author":"C King","year":"2021","unstructured":"King, C. & Sprent, J. Dual nature of type I interferons in SARS-CoV-2-induced inflammation. Trends Immunol. 42, 312\u2013322 (2021).","journal-title":"Trends Immunol."},{"key":"2640_CR44","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.it.2015.01.004","volume":"36","author":"H-H Hoffmann","year":"2015","unstructured":"Hoffmann, H.-H., Schneider, W. M. & Rice, C. M. Interferons and viruses: an evolutionary arms race of molecular interactions. Trends Immunol. 36, 124\u2013138 (2015).","journal-title":"Trends Immunol."},{"key":"2640_CR45","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1038\/s41392-023-01615-0","volume":"8","author":"Q Liu","year":"2023","unstructured":"Liu, Q. et al. Broadly neutralizing antibodies derived from the earliest COVID-19 convalescents protect mice from SARS-CoV-2 variants challenge. Signal Transduct. Target. Ther. 8, 347 (2023).","journal-title":"Signal Transduct. Target. Ther."},{"key":"2640_CR46","doi-asserted-by":"publisher","first-page":"840757","DOI":"10.3389\/fmicb.2022.840757","volume":"13","author":"F Tarr\u00e9s-Freixas","year":"2022","unstructured":"Tarr\u00e9s-Freixas, F. et al. Heterogeneous infectivity and pathogenesis of SARS-CoV-2 variants Beta, Delta and Omicron in transgenic K18-hACE2 and wildtype mice. Front. Microbiol. 13, 840757 (2022).","journal-title":"Front. Microbiol."},{"key":"2640_CR47","doi-asserted-by":"publisher","first-page":"105138","DOI":"10.1016\/j.antiviral.2021.105138","volume":"193","author":"ES Gan","year":"2021","unstructured":"Gan, E. S. et al. A mouse model of lethal respiratory dysfunction for SARS-CoV-2 infection. Antivir. Res. 193, 105138 (2021).","journal-title":"Antivir. Res."},{"key":"2640_CR48","first-page":"147","volume":"21","author":"O Puhach","year":"2023","unstructured":"Puhach, O., Meyer, B. & Eckerle, I. SARS-CoV-2 viral load and shedding kinetics. Nat. Rev. Microbiol. 21, 147\u2013161 (2023).","journal-title":"Nat. Rev. Microbiol."},{"key":"2640_CR49","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1126\/science.abc6027","volume":"369","author":"J Hadjadj","year":"2020","unstructured":"Hadjadj, J. et al. Impaired type I interferon activity and inflammatory responses in severe COVID-19 patients. Science 369, 718\u2013724 (2020).","journal-title":"Science"},{"key":"2640_CR50","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1038\/s41586-022-04421-w","volume":"603","author":"JD Domizio","year":"2022","unstructured":"Domizio, J. D. et al. The cGAS\u2013STING pathway drives type I IFN immunopathology in COVID-19. Nature 603, 145\u2013151 (2022).","journal-title":"Nature"},{"key":"2640_CR51","doi-asserted-by":"publisher","DOI":"10.1186\/s12915-025-02293-w","volume":"23","author":"C Ge","year":"2025","unstructured":"Ge, C. et al. Development and characterization of a fully humanized ACE2 mouse model. BMC Biol. 23, 194 (2025).","journal-title":"BMC Biol."},{"key":"2640_CR52","doi-asserted-by":"publisher","first-page":"816","DOI":"10.3390\/cells12050816","volume":"12","author":"A Leng","year":"2023","unstructured":"Leng, A. et al. Pathogenesis underlying neurological manifestations of long COVID syndrome and potential therapeutics. Cells 12, 816 (2023).","journal-title":"Cells"},{"key":"2640_CR53","doi-asserted-by":"publisher","first-page":"2350682","DOI":"10.1002\/eji.202350682","volume":"54","author":"M Fracella","year":"2024","unstructured":"Fracella, M. et al. Age-related transcript changes in type I interferon signaling in children and adolescents with long COVID. Eur. J. Immunol. 54, 2350682 (2024).","journal-title":"Eur. J. Immunol."},{"key":"2640_CR54","doi-asserted-by":"publisher","unstructured":"Lin, L. et al. Inflammatory signaling attenuates spliceosome function and cognitive ability. Autophagy 1\u201319, https:\/\/doi.org\/10.1080\/15548627.2025.2562882 (2025).","DOI":"10.1080\/15548627.2025.2562882"},{"key":"2640_CR55","doi-asserted-by":"publisher","first-page":"756262","DOI":"10.3389\/fimmu.2021.756262","volume":"12","author":"AE Spiering","year":"2021","unstructured":"Spiering, A. E. & de Vries, T. J. Why females do better: the X chromosomal TLR7 gene-dose effect in COVID-19. Front. Immunol. 12, 756262 (2021).","journal-title":"Front. Immunol."},{"key":"2640_CR56","doi-asserted-by":"publisher","first-page":"107764","DOI":"10.1016\/j.phrs.2025.107764","volume":"216","author":"S Schloer","year":"2025","unstructured":"Schloer, S. et al. The host cell factor DDX3 mediates sex dimorphism in the IFN\u03b1 response of plasmacytoid dendritic cells upon TLR activation. Pharmacol. Res. 216, 107764 (2025).","journal-title":"Pharmacol. Res."},{"key":"2640_CR57","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/j.celrep.2016.12.019","volume":"18","author":"P Charoentong","year":"2017","unstructured":"Charoentong, P. et al. Pan-cancer immunogenomic analyses reveal genotype-immunophenotype relationships and predictors of response to checkpoint blockade. Cell Rep. 18, 248\u2013262 (2017).","journal-title":"Cell Rep."},{"key":"2640_CR58","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/s41421-022-00517-9","volume":"9","author":"L Ai","year":"2023","unstructured":"Ai, L. et al. Lyophilized mRNA-lipid nanoparticle vaccines with long-term stability and high antigenicity against SARS-CoV-2. Cell Discov. 9, 9 (2023).","journal-title":"Cell Discov."},{"key":"2640_CR59","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1016\/j.cell.2014.10.010","volume":"159","author":"N Renier","year":"2014","unstructured":"Renier, N. et al. iDISCO: a simple, rapid method to immunolabel large tissue samples for volume imaging. Cell 159, 896\u2013910 (2014).","journal-title":"Cell"}],"container-title":["Signal Transduction and Targeted Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41392-026-02640-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41392-026-02640-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41392-026-02640-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T11:03:46Z","timestamp":1773659026000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41392-026-02640-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,16]]},"references-count":59,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2640"],"URL":"https:\/\/doi.org\/10.1038\/s41392-026-02640-5","relation":{},"ISSN":["2059-3635"],"issn-type":[{"value":"2059-3635","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,16]]},"assertion":[{"value":"11 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 January 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 February 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 March 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"97"}}